Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc (INDV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · INDV · as of Jun 8, 2026
Activity summary
Buy transactions
8
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Indivior Pharmaceuticals Inc insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
INDV insider buying and selling by quarter
INDV insider selling · INDV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · INDV ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
INDV executive sell shares · INDV board member insider trading · INDV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 13, 2026 | Thompson Juliet Director | Award | 6,518 | — | Form 4 |
| May 12, 2026 | Thompson Juliet Director | Other | 1,117 | $43K | Form 4 |
| May 13, 2026 | Humphreys Keith Director | Award | 6,518 | — | Form 4 |
| May 13, 2026 | Kingsley Stuart A Director | Award | 6,518 | — | Form 4 |
| May 13, 2026 | NINIVAGGI DANIEL A Director | Award | 6,518 | — | Form 4 |
| May 13, 2026 | Ryan Barbara Director | Award | 6,518 | — | Form 4 |
| May 13, 2026 | Stejbach Mark Director | Award | 6,518 | — | Form 4 |
| May 13, 2026 | Wheadon David E. Director | Award | 10,430 | — | Form 4 |
| Mar 14, 2026 | Preblick Ryan CFO | Option | 6,302 | — | Form 4 |
| Mar 14, 2026 | Preblick Ryan CFO | Other | 2,843 | $88K | Form 4 |
| Mar 13, 2026 | Ryan Barbara Director | Purchase | 8 | $249 | Form 4 |
| Mar 6, 2026 | Kingsley Stuart A Director | Purchase | 940 | $30K | Form 4 |
| Mar 9, 2026 | Ryan Barbara Director | Purchase | 31 | $1K | Form 4 |
| Mar 3, 2026 | Anderson Woodrow D CAO | Option | 18,364 | — | Form 4 |
| Mar 3, 2026 | Anderson Woodrow D CAO | Option | 5,946 | — | Form 4 |
| Mar 3, 2026 | Anderson Woodrow D CAO | Other | 2,682 | $86K | Form 4 |
| Mar 3, 2026 | Anderson Woodrow D CAO | Other | 8,283 | $265K | Form 4 |
| Mar 3, 2026 | Preblick Ryan CFO | Option | 86,949 | — | Form 4 |
| Mar 3, 2026 | Preblick Ryan CFO | Other | 87,597 | $2.80M⚡ | Form 4 |
| Mar 3, 2026 | Burris Jeffrey W Chief Legal Officer | Option | 79,893 | — | Form 4 |
| Mar 3, 2026 | Burris Jeffrey W Chief Legal Officer | Other | 36,032 | $1.15M⚡ | Form 4 |
| Mar 3, 2026 | Heidbreder Christian Chief Scientific Officer | Option | 101,544 | — | Form 4 |
| Mar 3, 2026 | Heidbreder Christian Chief Scientific Officer | Other | 45,797 | $1.46M⚡ | Form 4 |
| Feb 10, 2026 | Anderson Woodrow D CAO | Award | 6,903 | — | Form 4 |
| Feb 10, 2026 | Preblick Ryan CFO | Award | 37,358 | — | Form 4 |
Burris Jeffrey W
Chief Legal Officer
Date
Mar 3
Shares
36,032
Price
$31.98
Value
$1.15M ⚡
Heidbreder Christian
Chief Scientific Officer
Date
Mar 3
Shares
101,544
Price
—
Value
—
Heidbreder Christian
Chief Scientific Officer
Date
Mar 3
Shares
45,797
Price
$31.98
Value
$1.46M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About INDV insider trading
INDV insider trades
Indivior Pharmaceuticals Inc (INDV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Preblick Ryan (CFO), Anderson Woodrow D (CAO), Ryan Barbara (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. INDV insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Indivior Pharmaceuticals Inc's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
INDV insider trading · 5 questionsThe insiders of Indivior Pharmaceuticals Inc (INDV) include executives and directors such as Preblick Ryan (CFO), Anderson Woodrow D (CAO), Ryan Barbara (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026